Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

1-10 of 10 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

A phase I safety and efficacy clinical trial of plocabulin and gemcitabine in patients with advanced solid tumors.
Ghalib MH, Pulla MP, De Miguel Luken MJ, de Juan VC, Chaudhary I, Hammami MB, Vikash S, Maitra R, Martinez S, Kahatt C, Extremera S, Fudio S, Goel S
Invest New Drugs, 03 Aug 2024
Cited by: 0 articles | PMID: 39096398
Add to export list
A Descriptive Study of 103 Primary Cutaneous B-Cell Lymphomas: Clinical and Pathological Characteristics and Treatment from the Spanish Lymphoma Oncology Group (GOTEL).
Martínez-Banaclocha N, Martínez-Madueño F, Caballé B, Badia J, Blanes M, Bujanda DA, Calvo V, Gómez Codina J, Blanco CQ, Espinosa P, Lavernia J, Arroyo FRG, Risueño MG, Llorca C, Cumeras R, Pulla MP, Gumà J
Cancers (Basel), 16(5):1034, 03 Mar 2024
Cited by: 0 articles | PMID: 38473391 | PMCID: PMC10931196
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
A Descriptive Study of 103 Primary Cutaneous B-cell Lymphomas: Clinical and Pathological Characteristics and Treatment from the Spanish Lymphoma Oncology Group (Gotel)
Martínez-Banaclocha N, Martínez-Madueño F, Caballé B, Badia J, Blanes M, Bujanda DA, Calvo V, Gomez Codina J, Blanco CQ, Espinosa P, Lavernia J, Arroyo FRG, Risueño MG, Llorca C, Cumeras R, Pulla MP, Gumà J
Preprints.org, 15 Feb 2024
Cited by: 0 articles | PPR: PPR807103
Add to export list Preprint v1
SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer.
Borghaei H, de Marinis F, Dumoulin D, Reynolds C, Theelen WSME, Percent I, Gutierrez Calderon V, Johnson ML, Madroszyk-Flandin A, Garon EB, He K, Planchard D, Reck M, Popat S, Herbst RS, Leal TA, Shazer RL, Yan X, Harrigan R, [...] SAPPHIRE Investigators
Ann Oncol, 35(1):66-76, 20 Oct 2023
Cited by: 12 articles | PMID: 37866811
Add to export list
A randomised phase II study of osimertinib and bevacizumab versus osimertinib alone as second-line targeted treatment in advanced NSCLC with confirmed EGFR and acquired T790M mutations: the European Thoracic Oncology Platform (ETOP 10-16) BOOSTER trial.
Soo RA, Han JY, Dafni U, Cho BC, Yeo CM, Nadal E, Carcereny E, de Castro J, Sala MA, Bernabé R, Coate L, Provencio Pulla M, Garcia Campelo R, Cuffe S, Hashemi SMS, Früh M, Massuti B, Garcia-Sanchez J, Dómine M, [...] ETOP 10-16 BOOSTER Collaborators
Ann Oncol, 33(2):181-192, 26 Nov 2021
Cited by: 44 articles | PMID: 34839016
Add to export list
Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy - results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial.
Peters S, Pujol JL, Dafni U, Dómine M, Popat S, Reck M, Andrade J, Becker A, Moro-Sibilot D, Curioni-Fontecedro A, Molinier O, Nackaerts K, Insa Mollá A, Gervais R, López Vivanco G, Madelaine J, Mazieres J, Faehling M, Griesinger F, [...] ETOP/IFCT 4-12 STIMULI Collaborators
Ann Oncol, 33(1):67-79, 23 Sep 2021
Cited by: 38 articles | PMID: 34562610
Add to export list
Clinical pretreatment risk factors and prediction of outcome using gallium 67 scintigraphy in patients with Hodgkin's lymphoma.
Escobar IG, López A, Rubio J, Pérez-Callejo D, Barrigón DC, Alonso PT, Casado EA, Pulla MP
Mol Clin Oncol, 4(1):93-99, 09 Nov 2015
Cited by: 0 articles | PMID: 26870365 | PMCID: PMC4727096
Add to export list Free full text in Europe PMC
High-dose chemotherapy followed by autologous and allogeneic hematopoietic stem cell transplantation in patients with follicular non-Hodgkin’s lymphoma in the rituximab era.
Escobar IG, Sánchez de Ibarguen BC, de Juan VC, Alonso CM, García MM, Ruíz AC, Pulla MP
Tumori, 101(1):2-7, 01 Jan 2015
Cited by: 1 article | PMID: 25702654
Add to export list Review
Role of immune escape mechanisms in Hodgkin's lymphoma development and progression: a whole new world with therapeutic implications.
de la Cruz-Merino L, Lejeune M, Nogales Fernández E, Henao Carrasco F, Grueso López A, Illescas Vacas A, Pulla MP, Callau C, Álvaro T
Clin Dev Immunol, 2012:756353, 15 Aug 2012
Cited by: 22 articles | PMID: 22927872 | PMCID: PMC3426211
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Durable complete remission of a brainstem glioma treated with a combination of bevacizumab and cetuximab.
Blesa JM, Mollá SB, Esparcia MF, Ortells JM, Godoy MP, Das AM, Magan BM, Pulla MP, Sanchez JL, Canales JB, Candel VA
Case Rep Oncol, 5(3):676-681, 01 Sep 2012
Cited by: 5 articles | PMID: 23341811 | PMCID: PMC3551399
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC

1-10 of 10 results

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

Partnerships & funding